#United States #Los Angeles #Schall Law Firm #Securities Fraud #Geron Corporation

Know Your Rights as a Shareholder

In a crucial reminder to investors, the Schall Law Firm, a prominent national firm specializing in shareholder rights, has issued a notice regarding a class action lawsuit against Geron Corporation. This lawsuit is particularly significant for those investors who purchased Geron securities during the specified class period of June 7, 2024, to February 25, 2025. The firm encourages affected investors to take action before the deadline of May 12, 2025.

Background on Geron Corporation

Geron Corporation, trading under NASDAQ ticker GERN, is a clinical-stage biopharmaceutical company that focuses on developing therapies for oncology patients. Recent reports indicate that the company may have issued misleading information to investors regarding its financial outlook and growth potential. The crux of the lawsuit alleges violations of Section 10(b) and 20(a) of the Securities Exchange Act of 1934, specifically concerning the reporting of revenue expectations and the launch of their drug, Rytelo.

Specific Allegations

The class action centers around claims that Geron provided false and misleading statements to its investors. Investors were reportedly led to believe that the company had reliable information concerning its revenue projections and potential growth opportunities. However, it was later revealed that Geron had not appropriately communicated the challenges faced in launching Rytelo, including a lack of patient awareness which hindered its market performance.

These misleading representations caused investors to suffer damages when the facts became publicly known, fundamentally questioning the integrity of the company’s earlier statements. Hence, those who suffered losses during the class period are urged to join the lawsuit to seek compensation.

Joining the Class Action

If you are a shareholder impacted by Geron's actions, it is vital to participate in the class action to recover losses. Investors are invited to contact the Schall Law Firm at their Los Angeles office through phone at 310-301-3335 or via their website at www.schallfirm.com. Initial consultations are offered free of charge, allowing investors to understand their legal rights and options without financial obligation.

For those who choose to remain inactive, it’s essential to note that they may remain unrepresented as the class has not yet been certified. Taking no action could lead to being classified as an absent class member.

Conclusion

As a collective effort against corporate malfeasance, this lawsuit stands as a pivotal moment for investors to assert their rights and seek accountability. It serves as a reminder of the importance of staying informed and proactive in financial dealings, ensuring that you are not misled by potentially deceptive corporate communications. The Schall Law Firm has specialized in representing investors around the world and focuses on securities class action lawsuits aimed at protecting shareholder rights.

Stay vigilant, stay informed, and if impacted, consider joining this critical class action lawsuit against Geron Corporation.

Contact Information:
The Schall Law Firm
Brian Schall, Esq.
2049 Century Park East
Suite 2460
Los Angeles, CA 90067
Phone: 310-301-3335
Website: www.schallfirm.com
Email: [email protected]